Piramal Pharma Limited FII & DII Activity
5-Day Flow Trend
| Date | FII Net (₹ Cr) | DII Net (₹ Cr) |
|---|---|---|
| 2026-09-04 | −3111.94 | +8930.12 |
| 2026-09-03 | −2345.87 | +4977.46 |
| 2026-09-02 | +6688.37 | +2812.98 |
| 2026-09-01 | −7985.88 | +4588.88 |
| 2026-08-31 | −7985.88 | +4588.88 |
Today's Institutional Flow
On 4 September 2026, Foreign Institutional Investors posted a net cash outflow of ₹‑3,111.94 Cr, while Domestic Institutional Investors added ₹ 8,930.12 Cr to the market. The contrasting positions indicate that foreign participants are withdrawing capital, whereas domestic players are aggressively expanding their cash stakes. This divergence suggests a tilt toward domestic funding sources in the near‑term market dynamic.
Trend vs 5‑Day Average
The day’s FII cash outflow of ₹‑3,111.94 Cr is milder than the five‑day average outflow of ₹‑3,333.81 Cr, implying a slight easing of foreign selling pressure. Conversely, DII cash inflows of ₹ 8,930.12 Cr exceed the five‑day average of ₹ 4,430.43 Cr, highlighting a pronounced acceleration in domestic buying activity relative to the recent trend.
F&O Positioning Data
Foreign Institutional Investors hold a net F&O position of ₹ 374,795 Cr, underscoring a substantial speculative or hedging exposure in derivatives. Their index futures stance shows a long‑to‑short ratio of 1.2, indicating a modest bullish bias in the futures market.
Healthcare Sector Flow
The broader healthcare segment continues to attract net inflows from Domestic Institutional Investors, while Foreign Institutional Investors maintain a modest net outflow, reinforcing the sector’s reliance on domestic capital for the current cycle.
Market-wide FII/DII data — same for all F&O stocks. Date: 2026-09-04